IMQ is a selective synthetic agonist to toll-like receptor 7/8 (TLR7/8) [13], though it is advantageous, this specificity precludes mimicking many natural ligands that are involved in the induction of psoriasis. This evidence concerns the gene TLR7 and psoriasis.